U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Quotables

"Telephone, n. An invention of the devil which abrogates some of the advantages of making a disagreeable person keep his distance. "

Ambose Bierce

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 548/310.7 - Benzene ring bonded directly at the 2- position of the diazole ring


Subclass of Class 548 - Organic compounds -- part of the class 532-570 series
Definition: Compounds wherein a benzene ring is bonded directly to ring
No. of applications: 52
Last issue date: 02/28/2013


1    
Application No.Application TitleIssue Date
20130053412Cyclopentanecarboxamide derivatives, medicaments containing such compounds and their use
The invention relates to cyclopentanecarboxamide derivatives of formula 1, to their use as Fatty Acid Synthase inhibitors, to methods for their therapeutic use and to pharmaceutical compositions containing them, wherein R1, R2, R3, LO, W...
02/28/2013
201203130836,12-DINAPHTHYLCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE USING THE DERIVATIVE
Provided are an organic compound having high heat stability suitable for use in an organic light-emitting device, and an organic light-emitting device using the organic compound. The organic light-emitting device is an organic light-emitting device, including: an anode;...
12/13/2012
20120292601PHOSPHORESCENT HETEROLEPTIC PHENYLBENZIMIDAZOLE DOPANTS AND NEW SYNTHETIC METHODOLOGY
Novel heteroleptic iridium complexes are provided. These iridium complexes are useful compounds in OLED devices. The ligands for these novel complexes may be obtained using a new synthetic methodology that utilizes manganese dioxide....
11/22/2012
20120214804PHARMACEUTICAL COMPOSITION COMPRISING INDOLE COMPOUND
The present invention relates to a pharmaceutical composition comprising a compound of formula (1), (2) or (3) as defined in the specification for the prevention or treatment of diseases associated with oxidative stress, mitochondria dysfunction, hypoxic injury, necrosi...
08/23/2012
20120184556SUBSTITUTED ENZOIMIDAZOLESULFONAMIDES AND SUBSTITUTED INDOLESULFONAMIDES AS MGLUR4 POTENTIATORS
Disclosed are substituted benzoimidazolesulfonamides and substituted indolesulfonamides as mGluR4 potentiators....
07/19/2012
20120139410ORGANIC ELECTROLUMINESCENCE DEVICE AND MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE
An organic electroluminescence device includes: a cathode; an anode; and a single-layered or multilayered organic thin-film layer provided between the cathode and the anode. In the organic electroluminescence device, the organic thin-film layer includes at least one emi...
06/07/2012
20120132899NITROGENATED HETEROCYCLIC RING DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME
A nitrogen-containing heterocyclic derivative represented by the following formula (1):

wherein any “12-a” groups of R1 to R12 are independently a hydrogen atom, a fluorine atom, a s...

05/31/2012
20120126180NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES
The present invention relates to substituted benz[a]anthracene derivatives, to the preparation and use thereof in organic electroluminescent devices, and to organic electroluminescent devices, in particular blue-emitting devices, in which these compounds are used as mat...
05/24/2012
20120049768Fluorene Derivative, Organic Compound, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Compound
To provide a novel organic compound having a bipolar property. To reduce power consumption of a light-emitting element, a light-emitting device, and an electronic device. The organic compound has a fluorene skeleton and a structure in which an electron-accepting unit an...
03/01/2012
20120028959DIHYDROOROTATE DEHYDROGENASE INHIBITORS
The invention relates to compounds of formula (I) wherein R1, R2, X1, X2, Y, Ra, Rb, Q have the meanings given in claim 1. The compounds are useful e.g. in the treatment of autoimmune disorders, su...
02/02/2012
20110306611Transcription factor modulating compounds and methods of use thereof
Substituted benzoimidazole compounds useful as anti-infectives that decrease resistance, virulence, or growth of microbes are provided. Methods of making and using substituted benzoimidazole compounds, as well as pharmaceutical preparations thereof, in, e.g., reducing a...
12/15/2011
20110301146GLYCOGEN SYNTHASE KINASE-3 BETA INHIBITORS CONTAINING 7-HYDROXY-BENZOIMIDAZOLE-4-YL-METHANONE DERIVATIVES
GSK-3beta inhibitors comprising 7-Hydroxy-benzoimidazole-4-yl-methanone Derivatives are provided. For example, the inhibitors have following general formula (I).

...

12/08/2011
20110288292MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES
The present invention relates to substituted benzo[c]phenanthrene derivatives and to the production and to the use thereof in electronic devices, and to the electronic devices themselves. The present invention relates in particular to benzo[c]phenanthrene derivatives su...
11/24/2011
20110275663N-Acylthiourea and N-Acylurea Inhibitors of the Hedgehog Protein Signalling Pathway
The present invention relates to the use of acylthiourea or acylurea derivatives for the treatment of pathologies involving a tissue dysfunction associated with a deregulation of the Hedgehog protein signalling pathway, and also to novel acylthiourea or acylurea derivat...
11/10/2011
20110253994COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME AND DISPLAY DEVICE INCLUDING THE SAME
A compound for an organic optoelectronic device, an organic optoelectronic device including the same, and a display device including the same, the compound for an organic optoelectronic device being represented by the following Chemical Formula 1:

10/20/2011
20110251401POLYPHENYLENE HOST COMPOUNDS
Polyphenylene compounds such as compounds represented by Formula I may be used in electronic devices such as organic light-emitting devices. For example, the compounds may be used as host materials in a light-emitting layer....
10/13/2011
20110240980n-Type Doped Organic Materials and Methods Therefor
In accordance with various embodiments, an organic electronic device includes an n-type dopant material including an imidazole-based material having a hydrogen-based material bonded between nitrogen atoms. The n-type dopant material n-dopes an organic material, and can ...
10/06/2011
20110210320ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING THE SAME
The present invention relates to an anthracene derivative and an organic electroluminescent device using the same. More specifically, the present invention relates to: a novel compound which has a core (for example, an indenoanthracene core) where both an anthracene moi...
09/01/2011
20110195932Drug Combinations for the Treatment of Duchenne Muscular Dystrophy
Combinations comprising (or consisting essentially of) one or more compounds of formula (1) with one or more ancillary agents, to processes for preparing the combinations, and to various therapeutic uses of the combinations. Also provided are pharmaceutical compositions...
08/11/2011
20110140093COMPOUNDS FOR USE IN LIGHT-EMITTING DEVICES
Compounds including optionally substituted Ring Systems 1-4 may be used as hosts in light-emitting devices....
06/16/2011
20110095282ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING TRIAZINE DERIVATIVES
The invention relates to organic electroluminescent devices which comprise triazine derivatives as the electron transport material....
04/28/2011
20110077273NEW BENZIMIDAZOLE DERIVATIVES
The present invention relates to compounds of formula (I),

as well as pharmaceutically acceptable salts thereof can be used in the form of pharmaceutical compositions, wherein A, B, R1, R2

03/31/2011
20110046133ORGANIC COMPOUNDS
The present invention provides compounds of the following structure;


A-L1-B-C-D

that are useful for treating or preventing conditions or disorders associated with DGAT1 ac...

02/24/2011
20110040101ALANINE RACEMASE CHIRAL BINAPHTHOL DERIVATIVE WITH POWERFUL HYDROGEN BOND DONOR, AND OPTICAL RESOLUTION AND OPTICAL TRANSFORMATION METHODS USING THE SAME
Disclosed is an alanine racemase chiral binaphthol derivative having the ability to recognize amino alcohols selectively on the basis of chirality and transform amino acids from an L-form into a D-form. Methods for the optical resolution of amino acid or amino alcohol a...
02/17/2011
20110039895PROLYL HYDROXYLASE INHIBITORS
The invention described herein relates to certain benzimidazol-4-ylcarboxamide derivatives of formula (I)

which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from ...

02/17/2011
20110021532NOVEL SUBSTITUTED HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE
Substituted heteroaromatic compounds of structural formula I are inhibitors of stearoyl-coenzyme A delta-9 desaturase. The compounds of the present invention are useful for the prevention and treatment of conditions related to abnormal lipid synthesis and metabolism, in...
01/27/2011
20110012092NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME
A novel nitrogen-containing heterocyclic derivative having a specific structure. An organic electroluminescence device comprises an organic thin-film layer which is disposed between a cathode and an anode and comprises one or more layers having a light emitting layer. A...
01/20/2011
20100327270NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES
The present invention relates to the compounds of the formula (1) and to organic electroluminescent devices, in particular blue-emitting devices, in which these compounds are used as host material in the emitting layer and/or as electron-transport material....
12/30/2010
20100326526EMISSIVE ARYL-HETEROARYL COMPOUNDS
Disclosed herein are compounds represented by Formula 1, wherein R1, Ar1, X, Ar2, Ara, and Het are described herein. Compositions and light-emitting devices related thereto are also disclosed....
12/30/2010
20100252817New Anthracene Derivatives, Preparation Method Thereof and Organic Light Emitting Diode Using the Same
The present invention provides a novel anthracene derivative, a method for preparing the same, and an organic electronic device using the same. The anthracene derivative according to the invention can function alone as a light emitting host, in particular, as a blue hos...
10/07/2010
20100256203BENZIMIDAZOLES AND PHARMACEUTICAL COMPOSITIONS THEREOF
The present invention relates to novel benzimidazole derivatives and pharmaceutically acceptable salts thereof. Another aspect of the invention relates to methods of treating a patient infected by Mycobacterium tuberculosis or Francisella tulerensis by adm...
10/07/2010
20100239496Imaging agents for detecting neurological disorders
Imaging agents of formula (I) and methods for detecting neurological disorders comprising administering to a patient in need compounds of formula (I) capable of binding to tau proteins and β-amyloid peptides are presented herein. The invention also relates to methods o...
09/23/2010
20100240580AZOLOARINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICALS CONTAINING THESE COMPOUNDS AND THE USE THEREOF
The invention relates to azoloarine derivatives of formula I

wherein R, A, B, D, Y, X, M and W are as defined herein, and their physiologically tolerated salts....

09/23/2010
20100193773Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same
A novel derivative of heterocyclic compound having nitrogen atom with a structure made by bonding special groups to benzimidazole, a material for an organic electroluminescence (EL) device comprising the derivative of heterocyclic compound having nitrogen atom and an or...
08/05/2010
20100190826BENZIMIDAZOLE DERIVATIVE
Provided is a novel and excellent method for treating and/or preventing benign prostatic hyperplasia, prostate cancer, and the like based on selective inhibitory activity against 17βHSD type 5. It was found that an indole or benzimidazole derivative, where a nitrogen a...
07/29/2010
20100187505BENZANTHRACENE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENT DEVICES
The present invention relates to the compounds of the formula (1) and to organic electroluminescent devices, in particular blue-emitting devices, in which these compounds are used as host material or dopant in the emitting layer and/or as hole-transport material and/or ...
07/29/2010
20100179147BENZIMIDAZOLE COMPOUNDS AND THEIR USE AS ANTICANCER AGENTS
Benzimidazole compounds of formula (I):

wherein R1, R2, R3, R4, R5, X, Y, Z1, and Z2 are defined herein. Also disclosed is a method...

07/15/2010
20100120802Novel Anti-Inflammatory and Analgesic Heterocyclic Amidines that Inhibit Nitrogen Oxide (NO) Production
Heterocyclic amidines with anti-inflammatory and analgesic activity that inhibit nitrogen oxide production, of formula (I):

in which:

  • ...
05/13/2010
20100071769FLUORENE DERIVATIVES AND ORGANIC ELECTRONIC DEVICE USING THE SAME
Disclosed is a novel fluorene derivative and an organic electronic device using the same. The organic electronic device has excellent efficiency, driving voltage, and a lifespan....
03/25/2010
20100063122NOVEL 2-(2-HYDROXYPHENYL)BENZIMlDAZOLES USEFUL FOR TREATING OBESITY AND DIABETES
The present invention relates to novel compounds that act as chemical uncouplers. Compounds of the invention are useful, inter alia, in the treatment, including prevention, of obesity, diabetes and a number of diseases or conditions associated therewith....
03/11/2010
1    
 
Sign InRegister
Username  
Password   
forgot password?